Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic Mechanisms in Social Behavior
NCT04205994Phase 1Completed
- Sponsor
- University of California, Berkeley
- Start
- Dec 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Mental Disorders (MD) comparing Tolcapone with Placebo (2 arms). Primary endpoints: Behavioral responses in neuroeconomic tasks up to 4 weeks and Blood oxygen level dependent (BOLD) activity up to 4 weeks. Started Dec 2019; status: completed.
02
Drugs
tolcapone
03
Conditions
Mental Disorders (MD)
Beyond the preview
Go deeper on NCT04205994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205994.